Tenvie
1 known investors
Tenvie is a clinical-stage biopharmaceutical company developing small molecule and biologic therapeutics for neurological and peripheral diseases. The company is led by a team with expertise in biotech and precision medicine, targeting treatments for patients and caregivers affected by neurological conditions.
BiotechMedical Devices
Founders & leadership
TE
Tony EstradaPresident & Chief Executive Officer
Investors · 1
In the news
- Sell or Invest in Tenvie Therapeutics Stock Pre-IPOnasdaqprivatemarket.com · 2026
- Finance Watch: Aviceda, Tenvie Among Flurry Of Pre-J.P. Morgan VC Financingsinsights.citeline.com · 2025
- Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule Therapies - BioSpacebiospace.com · 2025
- Arch-backed Tenvie unveils with $200M and a neuro pipeline with assets from Denalifiercebiotech.com · 2025
- Tenvie raises $200M for brain drug R&D; Sana spikes on single patient’s results | BioPharma Divebiopharmadive.com · 2025
- Tenvie Therapeutics Raises $200M in Fundingfinsmes.com · 2025